शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ACUTAASNSEAcutaas Chemicals Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 11 Feb, 2026 · 19:01 IST

Acutaas subsidiary acquires 75% stake in South Korea's Indichem Inc

Listed-company acquisitionMarquee JV announcedStrategic Transactions View source PDFExplain this filing

ACUTAAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.5%Reaction day
₹2050.00
prior close
₹2043.60
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.7%+3.2% vs market
Pharmaceuticals peers, median of 157sector-0.7%+3.2% vs sector

On the reaction day the stock moved 3.2 pts more than Nifty Smallcap 250 and 3.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.0
10m
+0.2
15m
+0.2
30m
+0.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.5-0.7+3.2-0.7+3.2
Next day
-1.3-2.3+1.1-1.4+0.2
2d
-0.7-2.4+1.7-2.1+1.5
3d
+1.6-1.7+3.2-1.6+3.2
4d
+4.5-1.2+5.6-1.6+6.1
5d
+2.0-2.3+4.3-2.5+4.4
1w
+4.3-2.1+6.4-2.9+7.2
15d
+9.8-5.8+15.5-6.5+16.3
1m
+6.3-6.7+13.1-6.6+13.0
2m
+16.8-4.2+21.0-3.5+20.3
3m
+34.6+2.2+32.4+0.7+33.9
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Acutaas Chemicals' wholly owned subsidiary Acutaas Advance Material has completed acquiring 75% stake (300,000 shares) in Indichem Inc, a South Korean JV with J & Materials Co. Ltd. Indichem makes specialty chemicals for the semiconductor industry and now becomes a step-down subsidiary. Shares acquired at KRW 500 par value plus share premium, paid in cash. All regulatory approvals obtained. Manufacturing plant in South Korea is under construction, with commissioning expected by end of 2026.

Likely market impact

Positive: Acutaas enters global semiconductor chemicals market via South Korea step-down subsidiary, adding a new growth vertical beyond existing business.